Viral Stress-Inducible Genes

Advances in Virus Research

Volumn 70, Issue , 2007, Pages 233-263

  Sen, Ganes C ^a   Peters, Gregory A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; NONO PROTEIN, HUMAN; NUCLEAR MATRIX PROTEIN; OCTAMER TRANSCRIPTION FACTOR; P56 OLIGOADENYLATE SYNTHETASE; PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; PATHOGENICITY; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; VIROLOGY; VIRUS; VIRUS INFECTION;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MICE; NUCLEAR MATRIX-ASSOCIATED PROTEINS; OCTAMER TRANSCRIPTION FACTORS; PROTEIN BIOSYNTHESIS; PROTEINS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; VIRUS DISEASES; VIRUSES;

EID: 34548246501     PISSN: 00653527     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-3527(07)70006-4     Document Type: Review

References (129)

1. Abraham N., Stojdl D.F., Duncan P.I., Methot N., Ishii T., Dube M., Vanderhyden B.C., Atkins H.L., Gray D.A., McBurney M.W., Koromilas A.E., Brown E.G., et al. Characterization of transgenic mice with targeted disruption of the catalytic domain of the double-stranded RNA-dependent protein kinase, PKR. J. Biol. Chem. 274 9 (1999) 5953-5962
2. Andrejeva J., Childs K.S., Young D.F., Carlos T.S., Stock N., Goodbourn S., and Randall R.E. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. USA 101 49 (2004) 17264-17269
3. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 6857 (2001) 732-738
4. Barro M., and Patton J.T. Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc. Natl. Acad. Sci. USA 102 11 (2005) 4114-4119
5. Bell J.K., Botos I., Hall P.R., Askins J., Shiloach J., Segal D.M., and Davies D.R. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc. Natl. Acad. Sci. USA 102 31 (2005) 10976-10980
6. Best S.M., Morris K.L., Shannon J.G., Robertson S.J., Mitzel D.N., Park G.S., Boer E., Wolfinbarger J.B., and Bloom M.E. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J. Virol. 79 20 (2005) 12828-12839
7. Bieback K., Lien E., Klagge I.M., Avota E., Schneider-Schaulies J., Duprex W.P., Wagner H., Kirschning C.J., Ter Meulen V., and Schneider-Schaulies S. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J. Virol. 76 17 (2002) 8729-8736
8. Biron C., and Sen G.C. Interferons and other cytokines. In: Knipe D., Howley P., Griffin D., Lamb R., Martin M., and Straus S. (Eds). "Fields Virology". 4th Ed. Vol. 1 (2001), Williams & Wilkins, Philadelphia, Lippincott 321-351
9. Bluyssen H.A., Vlietstra R.J., Faber P.W., Smit E.M., Hagemeijer A., and Trapman J. Structure, chromosome localization, and regulation of expression of the interferon-regulated mouse Ifi54/Ifi56 gene family. Genomics 24 1 (1994) 137-148
10. Breiman A., Grandvaux N., Lin R., Ottone C., Akira S., Yoneyama M., Fujita T., Hiscott J., and Meurs E.F. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon. J. Virol. 79 7 (2005) 3969-3978
11. Brukman A., and Enquist L.W. Suppression of the interferon-mediated innate immune response by pseudorabies virus. J. Virol. 80 13 (2006) 6345-6356
12. Brzozka K., Finke S., and Conzelmann K.K. Inhibition of interferon signaling by rabies virus phosphoprotein P: Activation-dependent binding of STAT1 and STAT2. J. Virol. 80 6 (2006) 2675-2683
13. Cardenas W.B., Loo Y.M., Gale Jr. M., Hartman A.L., Kimberlin C.R., Martinez-Sobrido L., Saphire E.O., and Basler C.F. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J. Virol. 80 11 (2006) 5168-5178
14. Cassady K.A. Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection. J. Virol. 79 14 (2005) 8707-8715
15. Cheng G., Zhong J., and Chisari F.V. Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 103 22 (2006) 8499-8504
16. Child S.J., Hakki M., De Niro K.L., and Geballe A.P. Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J. Virol. 78 1 (2004) 197-205
17. Choe J., Kelker M.S., and Wilson I.A. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 309 5734 (2005) 581-585
18. Compton T., Kurt-Jones E.A., Boehme K.W., Belko J., Latz E., Golenbock D.T., and Finberg R.W. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77 8 (2003) 4588-4596
19. Crozat K., and Beutler B. TLR7: A new sensor of viral infection. Proc. Natl. Acad. Sci. USA 101 18 (2004) 6835-6836
20. D'Andrea L.D., and Regan L. TPR proteins: The versatile helix. Trends Biochem. Sci 28 12 (2003) 655-662
21. Dar A.C., Dever T.E., and Sicheri F. Higher-order substrate recognition of eIF2alpha by the RNA-dependent protein kinase PKR. Cell 122 6 (2005) 887-900
22. DeFilippis V., and Fruh K. Rhesus cytomegalovirus particles prevent activation of interferon regulatory factor 3. J. Virol. 79 10 (2005) 6419-6431
23. de Los Santos T., de Avila Botton S., Weiblen R., and Grubman M.J. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 80 4 (2006) 1906-1914
24. Der S.D., Zhou A., Williams B.R., and Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95 26 (1998) 15623-15628
25. de Veer M.J., Sim H., Whisstock J.C., Devenish R.J., and Ralph S.J. IFI60/ISG60/IFIT4, a new member of the human IFI54/IFIT2 family of interferon-stimulated genes. Genomics 54 2 (1998) 267-277
26. Dey M., Cao C., Dar A.C., Tamura T., Ozato K., Sicheri F., and Dever T.E. Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition. Cell 122 6 (2005) 901-913
27. Diebold S.S., Kaisho T., Hemmi H., Akira S., and Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 5663 (2004) 1529-1531
28. Donelan N.R., Dauber B., Wang X., Basler C.F., Wolff T., and Garcia-Sastre A. The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation. J. Virol. 78 21 (2004) 11574-11582
29. Elco C.P., Guenther J.M., Williams B.R., and Sen G.C. Analysis of genes induced by Sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-kappaB, and interferon but not toll-like receptor 3. J. Virol. 79 7 (2005) 3920-3929
30. Fensterl V., Grotheer D., Berk I., Schlemminger S., Vallbracht A., and Dotzauer A. Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon. J. Virol. 79 17 (2005) 10968-10977
31. Fernandez-Sesma A., Marukian S., Ebersole B.J., Kaminski D., Park M.S., Yuen T., Sealfon S.C., Garcia-Sastre A., and Moran T.M. Influenza virus evades innate and adaptive immunity via the NS1 protein. J. Virol. 80 13 (2006) 6295-6304
32. Ferreon J.C., Ferreon A.C., Li K., and Lemon S.M. Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease. J. Biol. Chem. 280 21 (2005) 20483-20492
33. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., and Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4 5 (2003) 491-496
34. Foy E., Li K., Sumpter Jr. R., Loo Y.M., Johnson C.L., Wang C., Fish P.M., Yoneyama M., Fujita T., Lemon S.M., and Gale Jr. M. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. USA 102 8 (2005) 2986-2991
35. Fredericksen B.L., and Gale Jr. M. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J. Virol. 80 6 (2006) 2913-2923
36. Freundt E.C., and Lenardo M.J. Interfering with interferons: Hepatitis C virus counters innate immunity. Proc. Natl. Acad. Sci. USA 102 49 (2005) 17539-17540
37. Galabru J., and Hovanessian A. Autophosphorylation of the protein kinase dependent on double-stranded RNA. J. Biol. Chem. 262 32 (1987) 15538-15544
38. Gale Jr. M., and Katze M.G. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78 1 (1998) 29-46
39. Geiss G., Jin G., Guo J., Bumgarner R., Katze M.G., and Sen G.C. A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling. J. Biol. Chem. 276 32 (2001) 30178-30182
40. Ghosh A., Sarkar S.N., Rowe T.M., and Sen G.C. A specific isozyme of 2′-5′ oligoadenylate synthetase is a dual function proapoptotic protein of the bcl-2 family. J. Biol. Chem. 276 27 (2001) 25447-25455
41. Green S.R., and Mathews M.B. Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI. Genes Dev. 6 12B (1992) 2478-2490
42. Guillot L., Le Goffic R., Bloch S., Escriou N., Akira S., Chignard M., and Si-Tahar M. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280 7 (2005) 5571-5580
43. Guo J., Peters K.L., and Sen G.C. Induction of the human protein P56 by interferon, double-stranded RNA, or virus infection. Virology 267 2 (2000) 209-219
44. Guo J., Hui D.J., Merrick W.C., and Sen G.C. A new pathway of translational regulation mediated by eukaryotic initiation factor 3. EMBO J. 19 24 (2000) 6891-6899
45. Guo J.T., Hayashi J., and Seeger C. West Nile virus inhibits the signal transduction pathway of alpha interferon. J. Virol. 79 3 (2005) 1343-1350
46. Hakki M., Marshall E.E., De Niro K.L., and Geballe A.P. Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1. J. Virol. 80 23 (2006) 11817-11826
47. Hartman A.L., Dover J.E., Towner J.S., and Nichol S.T. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication. J. Virol. 80 13 (2006) 6430-6440
48. Hartmann R., Rebouillat D., Justesen J., Sen G.C., and Williams B.R. The P59 oligoadenylate synthetase like protein (P59OASL) does not display oligoadenylate synthetase activity but posses anti-viral properties conferred by an ubiquitin-like domain. J. Interferon Cytokine Res. 21 9 (2001) S-18
49. Hartmann R., Justesen J., Sen G.C., and Yee V.C. The crystal structure of 2′-5′ oligoadenylate synthetase provides structural evidence for a common catalytic mechanism for 3′ and 2′ specific nucleotidyl transferases. J. Interferon Cytokine Res. 22 9 (2002) S-143
50. Hartmann R., Justesen J., Sarkar S.N., Sen G.C., and Yee V.C. Crystal structure of the 2′-specific and double-stranded RNA-activated interferon-induced antiviral protein 2′-5′-oligoadenylate synthetase. Mol. Cell 12 5 (2003) 1173-1185
51. He B., Gross M., and Roizman B. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 94 3 (1997) 843-848
52. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 408 6813 (2000) 740-745
53. Hoebe K., Du X., Georgel P., Janssen E., Tabeta K., Kim S.O., Goode J., Lin P., Mann N., Mudd S., Crozat K., Sovath S., et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signaling. Nature 424 6950 (2003) 743-748
54. Hofmann K., and Bucher P. The PCI domain: A common theme in three multiprotein complexes. Trends Biochem. Sci 23 6 (1998) 204-205
55. Hornung V., Ellegast J., Kim S., Brzozka K., Jung A., Kato H., Poeck H., Akira S., Conzelmann K.K., Schlee M., Endres S., and Hartmann G. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314 5801 (2006) 994-997
56. Horvath C.M. Silencing STATs: Lessons from paramyxovirus interferon evasion. Cytokine Growth Factor Rev. 15 2-3 (2004) 117-127
57. Hovanessian A.G. Interferon-induced and double-stranded RNA-activated enzymes: A specific protein kinase and 2′,5′-oligoadenylate synthetases. J. Interferon Res. 11 4 (1991) 199-205
58. Huang X., Hutchins B., and Patel R.C. The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR). Biochem. J. 366 Pt. 1 (2002) 175-186
59. Hui D.J., Bhasker C.R., Merrick W.C., and Sen G.C. Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.Met-tRNAi. J. Biol. Chem. 278 41 (2003) 39477-39482
60. Hui D.J., Terenzi F., Merrick W.C., and Sen G.C. Mouse p56 blocks a distinct function of eukaryotic initiation factor 3 in translation initiation. J. Biol. Chem. 280 5 (2005) 3433-3440
61. Ito T., Yang M., and May W.S. RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling. J. Biol. Chem. 274 22 (1999) 15427-15432
62. Jennings S., Martinez-Sobrido L., Garcia-Sastre A., Weber F., and Kochs G. Thogoto virus ML protein suppresses IRF3 function. Virology 331 1 (2005) 63-72
63. Jones M., Davidson A., Hibbert L., Gruenwald P., Schlaak J., Ball S., Foster G.R., and Jacobs M. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J. Virol. 79 9 (2005) 5414-5420
64. Krug A., Luker G.D., Barchet W., Leib D.A., Akira S., and Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 103 4 (2004) 1433-1437
65. La Rocca S.A., Herbert R.J., Crooke H., Drew T.W., Wileman T.E., and Powell P.P. Loss of interferon regulatory factor 3 in cells infected with classical swine fever virus involves the N-terminal protease, Npro. J. Virol. 79 11 (2005) 7239-7247
66. Leib D.A., Machalek M.A., Williams B.R., Silverman R.H., and Virgin H.W. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc. Natl. Acad. Sci. USA 97 11 (2000) 6097-6101
67. Lengyel P. Double-stranded RNA and interferon action. J. Interferon Res 7 5 (1987) 511-519
68. Li S., Min J.Y., Krug R.M., and Sen G.C. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349 1 (2006) 13-21
69. Li S., Peters G.A., Ding K., Zhang X., Qin J., and Sen G.C. Molecular basis for PKR activation by PACT or dsRNA. Proc. Natl. Acad. Sci. USA 103 26 (2006) 10005-10010
70. Li K., Foy E., Ferreon J.C., Nakamura M., Ferreon A.C., Ikeda M., Ray S.C., Gale Jr. M., and Lemon S.M. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA 102 8 (2005) 2992-2997
71. Li X.D., Sun L., Seth R.B., Pineda G., and Chen Z.J. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad. Sci. USA 102 49 (2005) 17717-17722
72. Liang X., Shin Y.C., Means R.E., and Jung J.U. Inhibition of interferon-mediated antiviral activity by murine gammaherpesvirus 68 latency-associated M2 protein. J. Virol. 78 22 (2004) 12416-12427
73. Lin W., Kim S.S., Yeung E., Kamegaya Y., Blackard J.T., Kim K.A., Holtzman M.J., and Chung R.T. Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J. Virol. 80 18 (2006) 9226-9235
74. Liu W.J., Wang X.J., Mokhonov V.V., Shi P.Y., Randall R., and Khromykh A.A. Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J. Virol. 79 3 (2005) 1934-1942
75. Liu W.J., Wang X.J., Clark D.C., Lobigs M., Hall R.A., and Khromykh A.A. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J. Virol. 80 5 (2006) 2396-2404
76. Loo Y.M., Owen D.M., Li K., Erickson A.K., Johnson C.L., Fish P.M., Carney D.S., Wang T., Ishida H., Yoneyama M., Fujita T., Saito T., et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 103 15 (2006) 6001-6006
77. Lund J.M., Alexopoulou L., Sato A., Karow M., Adams N.C., Gale N.W., Iwasaki A., and Flavell R.A. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101 15 (2004) 5598-5603
78. Marchetti A., Buttitta F., Miyazaki S., Gallahan D., Smith G.H., and Callahan R. Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. J. Virol. 69 3 (1995) 1932-1938
79. Marcus P.I., Rojek J.M., and Sekellick M.J. Interferon induction and/or production and its suppression by influenza A viruses. J. Virol. 79 5 (2005) 2880-2890
80. Marie I., Svab J., Robert N., Galabru J., and Hovanessian A.G. Differential expression and distinct structure of 69- and 100-kDa forms of 2-5A synthetase in human cells treated with interferon. J. Biol. Chem. 265 30 (1990) 18601-18607
81. Martinez-Sobrido L., Zuniga E.I., Rosario D., Garcia-Sastre A., and de la Torre J.C. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 80 18 (2006) 9192-9199
82. Mashimo T., Lucas M., Simon-Chazottes D., Frenkiel M.P., Montagutelli X., Ceccaldi P.E., Deubel V., Guenet J.L., and Despres P. A nonsense mutation in the gene encoding 2′-5′-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc. Natl. Acad. Sci. USA 99 17 (2002) 11311-11316
83. Micklem D.R., Adams J., Grunert S., and St. Johnston D. Distinct roles of two conserved Staufen domains in oskar mRNA localization and translation. EMBO J. 19 6 (2000) 1366-1377
84. Meurs E., Chong K., Galabru J., Thomas N.S., Kerr I.M., Williams B.R., and Hovanessian A.G. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62 2 (1990) 379-390
85. Nanduri S., Carpick B.W., Yang Y., Williams B.R., and Qin J. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J. 17 18 (1998) 5458-5465
86. Nanduri S., Rahman F., Williams B.R., and Qin J. A dynamically tuned double-stranded RNA binding mechanism for the activation of antiviral kinase PKR. EMBO J. 19 20 (2000) 5567-5574
87. Niikura T., Hirata R., and Weil S.C. A novel interferon-inducible gene expressed during myeloid differentiation. Blood Cells Mol. Dis 23 3 (1997) 337-349
88. Patel C.V., Handy I., Goldsmith T., and Patel R.C. PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J. Biol. Chem. 275 48 (2000) 37993-37998
89. Patel R.C., and Sen G.C. Identification of the double-stranded RNA-binding domain of the human interferon-inducible protein kinase. J. Biol. Chem. 267 11 (1992) 7671-7676
90. Patel R.C., and Sen G.C. PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 17 15 (1998) 4379-4390
91. Patel R.C., Stanton P., McMillan N.M., Williams B.R., and Sen G.C. The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo. Proc. Natl. Acad. Sci. USA 92 18 (1995) 8283-8287
92. Patel R.C., Stanton P., and Sen G.C. Specific mutations near the amino terminus of double-stranded RNA-dependent protein kinase (PKR) differentially affect its double-stranded RNA binding and dimerization properties. J. Biol. Chem. 271 41 (1996) 25657-25663
93. Paulus C., Krauss S., and Nevels M. A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proc. Natl. Acad. Sci. USA 103 10 (2006) 3840-3845
94. Peters G.A., Hartmann R., Qin J., and Sen G.C. Modular structure of PACT: Distinct domains for binding and activating PKR. Mol. Cell Biol. 21 6 (2001) 1908-1920
95. Peters G.A., Khoo D., Mohr I., and Sen G.C. Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein. J. Virol. 76 21 (2002) 11054-11064
96. Peters G.A., Li S., and Sen G.C. Phosphorylation of specific serine residues in the PKR activation domain of PACT is essential for its ability to mediate apoptosis. J. Biol. Chem. 281 46 (2006) 35129-35136
97. Pichlmair A., Schulz O., Tan C.P., Naslund T.I., Liljestrom P., Weber F., and Reis e Sousa C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314 5801 (2006) 997-1001
98. Polack F.P., Irusta P.M., Hoffman S.J., Schiatti M.P., Melendi G.A., Delgado M.F., Laham F.R., Thumar B., Hendry R.M., Melero J.A., Karron R.A., Collins P.L., et al. The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin. Proc. Natl. Acad. Sci. USA 102 25 (2005) 8996-9001
99. Rebouillat D., Hovnanian A., Marie I., and Hovanessian A.G. The 100-kDa 2′, 5′-oligoadenylate synthetase catalyzing preferentially the synthesis of dimeric pppA2′p5′A molecules is composed of three homologous domains [In Process Citation]. J. Biol. Chem. 274 3 (1999) 1557-1565
100. Rowe T.M., Rizzi M., Hirose K., Peters G.A., and Sen G.C. A role of the double-stranded RNA-binding protein PACT in mouse ear development and hearing. Proc. Natl. Acad. Sci. USA 103 15 (2006) 5823-5828
101. Samuel C.E. The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem. 268 11 (1993) 7603-7606
102. Sarkar S.N., and Sen G.C. Novel functions of proteins encoded by viral stress-inducible genes. Pharmacol. Ther. 103 3 (2004) 245-259
103. Sarkar S.N., Bandyopadhyay S., Ghosh A., and Sen G.C. Enzymatic characteristics of recombinant medium isozyme of 2′-5′ oligoadenylate synthetase. J. Biol. Chem. 274 3 (1999) 1848-1855
104. Sarkar S.N., Ghosh A., Wang H.W., Sung S.S., and Sen G.C. The nature of the catalytic domain of 2′-5′-oligoadenylate synthetases. J. Biol. Chem. 274 36 (1999) 25535-25542
105. Sarkar S.N., Miyagi M., Crabb J.W., and Sen G.C. Identification of the substrate-binding sites of 2′-5′-oligoadenylate synthetase. J. Biol. Chem. 277 27 (2002) 24321-24330
106. Sarkar S.N., Pal S., and Sen G.C. Crisscross enzymatic reaction between the two molecules in the active dimeric P69 form of the 2′-5′ oligodenylate synthetase. J. Biol. Chem. 277 47 (2002) 44760-44764
107. Sarkar S.N., Smith H.L., Rowe T.M., and Sen G.C. Double-stranded RNA signaling by toll-like receptor 3 requires specific tyrosine residues in its cytoplasmic domain. J. Biol. Chem. 278 7 (2003) 4393-4396
108. Sarkar S.N., Peters K.L., Elco C.P., Sakamoto S., Pal S., and Sen G.C. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat. Struct. Mol. Biol 11 11 (2004) 1060-1067
109. Sarkar S.N., Elco C.P., Peters K.L., Chattopadhyay S., and Sen G.C. Two tyrosine residues of toll-like receptor 3 trigger different steps of NF-kappa B activation. J. Biol. Chem. 282 6 (2007) 3423-3427
110. Schlender J., Hornung V., Finke S., Gunthner-Biller M., Marozin S., Brzozka K., Moghim S., Endres S., Hartmann G., and Conzelmann K.K. Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J. Virol. 79 9 (2005) 5507-5515
111. Shaw M.L., Cardenas W.B., Zamarin D., Palese P., and Basler C.F. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J. Virol. 79 10 (2005) 6078-6088
112. Silverman R.H., and Cirino N.M. mRNA metabolism and post-translational gene regulation. In: Morris D.R., and Hartford J.B. (Eds). "Gene Regulation" (1997), Wiley & Sons, New York 295-309
113. Spann K.M., Tran K.C., and Collins P.L. Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines. J. Virol. 79 9 (2005) 5353-5362
114. St Johnston D., Driever W., Berleth T., Richstein S., and Nusslein-Volhard C. Multiple steps in the localization of bicoid RNA to the anterior pole of the Drosophila oocyte. Development 107 Suppl. (1989) 13-19
115. St Johnston D., Beuchle D., and Nusslein-Volhard C. Staufen, a gene required to localize maternal RNAs in the Drosophila egg. Cell 66 1 (1991) 51-63
116. Stack J., Haga I.R., Schroder M., Bartlett N.W., Maloney G., Reading P.C., Fitzgerald K.A., Smith G.L., and Bowie A.G. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med 201 6 (2005) 1007-1018
117. Tabeta K., Georgel P., Janssen E., Du X., Hoebe K., Crozat K., Mudd S., Shamel L., Sovath S., Goode J., Alexopoulou L., Flavell R.A., et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 101 10 (2004) 3516-3521
118. Taylor R.T., and Bresnahan W.A. Human cytomegalovirus immediate-early 2 gene expression blocks virus-induced beta interferon production. J. Virol. 79 6 (2005) 3873-3877
119. Terenzi F., Pal S., and Sen G.C. Induction and mode of action of the viral stress-inducible murine proteins, P56 and P54. Virology 340 1 (2005) 116-124
120. Terenzi F., Hui D.J., Merrick W.C., and Sen G.C. Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J. Biol. Chem. 281 45 (2006) 34064-34071
121. Wacher C., Muller M., Hofer M.J., Getts D.R., Zabaras R., Ousman S.S., Terenzi F., Sen G.C., King N.J., and Campbell I.L. Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J. Virol. 81 2 (2007) 860-871
122. Wang C., Pflugheber J., Sumpter Jr. R., Sodora D.L., Hui D., Sen G.C., and Gale Jr. M. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J. Virol. 77 7 (2003) 3898-3912
123. Wathelet M.G., Clauss I.M., Content J., and Huez G.A. The IFI-56K and IFI-54K interferon-inducible human genes belong to the same gene family. FEBS Lett 231 1 (1988) 164-171
124. Williams B.R. Signal integration via PKR. Sci STKE 2001 89 (2001) RE2
125. Yang Y.L., Reis L.F., Pavlovic J., Aguzzi A., Schafer R., Kumar A., Williams B.R., Aguet M., and Weissmann C. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14 24 (1995) 6095-6106
126. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., and Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5 7 (2004) 730-737
127. Yu M., Tong J.H., Mao M., Kan L.X., Liu M.M., Sun Y.W., Fu G., Jing Y.K., Yu L., Lepaslier D., Lanotte M., Wang Z.Y., et al. Cloning of a gene (RIG-G) associated with retinoic acid-induced differentiation of acute promyelocytic leukemia cells and representing a new member of a family of interferon-stimulated genes. Proc. Natl. Acad. Sci. USA 94 14 (1997) 7406-7411
128. Yu Y., Wang S.E., and Hayward G.S. The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22 1 (2005) 59-70
129. Zhu F.X., King S.M., Smith E.J., Levy D.E., and Yuan Y. A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc. Natl. Acad. Sci. USA 99 8 (2002) 5573-5578